Olink Publishes 2023 Annual Report
Olink Publishes 2023 Annual Report
UPPSALA, Sweden, March 25, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) ("Olink") (Nasdaq: OLK) today announced that the Annual Report for 2023 is now available on the Company's website at https://investors.olink.com/.
瑞典乌普萨拉，2024年3月25日（GLOBE NEWSWIRE）——Olink Holding AB（publ）（“Olink”）（纳斯达克股票代码：OLK）今天宣布，2023年年度报告现已在公司网站上发布，网址为 https://investors.olink.com/。
About Olink
Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The Company was founded in 2016 and is well established across Europe, North America, and Asia. Olink is headquartered in Uppsala, Sweden.
关于 Olink
Olink Holding AB（纳斯达克股票代码：OLK）是一家致力于与科学界一起加速跨多个疾病领域的蛋白质组学的公司，以实现新发现并改善患者的生活。Olink提供了一个产品和服务平台，这些产品和服务部署在主要的生物制药公司以及领先的临床和学术机构，以加深对实时人类生物学的理解，并通过切实可行和有影响力的科学推动21世纪的医疗保健。该公司成立于2016年，在欧洲、北美和亚洲都享有盛誉。Olink 总部位于瑞典乌普萨拉。
IR contact
David Deuchler, CFA
Gilmartin Group
olink@gilmartinir.com
红外联系人
David Deuchler，特许金融分析师
吉尔马丁集团
olink@gilmartinir.com
Media contact
Michael B. Gonzales
VP Global Marketing
Mobile: +1 415 308 6467
michael.gonzales@olink.com
媒体联系人
迈克尔·冈萨雷斯
全球营销副总裁
手机：+1 415 308 6467
michael.gonzales@olink.com
译文内容由第三方软件翻译。